Nowakowski is an early-career researcher (h-index ≈1) whose most-cited contribution is a 2020 Frontiers in Bioengineering paper (≈60 citations) on improving a three-layered in vitro skin model, with follow-up work (2024–2025) on wound models, adipocyte–macrophage co-cultures, and biodegradable nanoparticle systems for atorvastatin delivery — productive in tissue-engineering/in vitro model space but limited publication volume and citation breadth so far (<70 total cited_by counts in OpenAlex)
Most-cited work: 2020 Frontiers paper (≈60 citations) — primary evidence of impact so far
| Year | Title | Journal | DOI / OA | Reported cited_by |
|---|---|---|---|---|
| 2020 | Improvement of a Three-Layered in vitro Skin Model for Topical Application of Irritating Substances | Frontiers in Bioengineering and Biotechnology | 10.3389/fbioe.2020.00388 (OA) | ~60 |
| 2024 | Development of an in vitro three-layered skin wound healing model for pre-clinical testing | Current Directions in Biomedical Engineering | 10.1515/cdbme-2024-2113 (OA) | 1 |
| 2025 | Engineered biodegradable polymeric nanoparticles injectable system of atorvastatin for improved therapeutic activity | Scientific Reports | 10.1038/s41598-025-31548-3 (OA) | 0 |
| 2025 | Animal‐Free Setup of a 3D Mature Adipocyte‐Macrophage Co‐Culture to Induce Inflammation In Vitro | Advanced Healthcare Materials | 10.1002/adhm.202500779 (OA/hybrid) | 0 |
Limitations & blindspots (concise): small publication count; concentration of impact in one work (risk of over-reliance on single paper); few first/last author senior outputs visible; limited independent institutional/PI visibility in OpenAlex metadata; recent 2024–2025 outputs are too new for citation-based validation. Consider potential biases like collaborative credit distribution (middle-author placements) and small-sample bibliometrics for early-career evaluation.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.